LG CNS Lacks Treasury Shares — What Tools Does It Have to Boost Its Stock?

[Korea Financial Times, Jeong Chaeyun] LG CNS has sidestepped the risks posed by the amended Commercial Act by holding zero treasury shares. While earnings and dividends remain on a stable trajectory, the company's stock has lingered at roughly half its all-time high, and market observers say it conspicuously lacks ready tools to prop up its share price.

The Market LG CNS Faces With Zero Treasury Shares: A Paradox

According to LG CNS, as of end of last year, the company holds zero treasury shares out of a total of 96,885,948 shares in circulation.

As a result, LG CNS is free from the mandatory cancellation requirements under the third round of proposed Commercial Act amendments. Under the proposed revision, newly acquired treasury shares must be cancelled or disposed of within one year of acquisition, while shares already held must be cancelled or disposed of within 18 months of the effective date.

While this may appear to position LG CNS favorably from a regulatory standpoint, the market's reading is somewhat different.

Treasury shares are not simply an accounting item — they function as the fastest shareholder return tool management can deploy when a stock comes under pressure. With no existing holdings, LG CNS would have to purchase treasury shares from scratch to defend its share price, inevitably requiring a cash outlay.

CEO Hyun Shin-kyun's personal open-market purchase of 2,500 shares (KRW 150 million) on the 3rd of this month has been interpreted as a signal of responsible management, but it does nothing to address the structural limitation of zero corporate-level treasury shares. Moreover, the purchase represents just 0.0026% of the total 96.88 million shares outstanding, making any meaningful price support effect negligible.

In short, being free from cancellation obligations does not translate directly into greater capacity to boost the stock price. If anything, the market interprets the situation as a shortage of immediate tools to underpin the share price.

This concern is particularly acute as valuations in the technology, AI, and cloud services sectors become increasingly volatile. In such an environment, share buybacks and cancellations are widely recognized as a primary mechanism for setting a floor under a stock price while simultaneously lifting return on equity (ROE) and earnings per share (EPS).

The fact that LG CNS is structurally unable to deploy such tools represents a clear vulnerability in the eyes of investors.

Strong Earnings, but Stock Price Cut in Half

The company's fundamentals are solid. LG CNS has maintained a consistent growth trajectory since CEO Hyun Shin-kyun took office in March 2023.

In particular, the company posted record-high results last year on a consolidated basis, with revenue of KRW 6.1295 trillion and operating profit of KRW 555.8 billion — increases of 2.5% and 8.4%, respectively, from the prior year. Expanding demand for cloud migration and growth in industrial AI-based system integration (SI) business have jointly contributed to continued improvements in operating margin. LG CNS's operating margin surpassed 9% last year, up 0.5 percentage points from the prior year.
The year-end dividend was reduced somewhat — from KRW 1,672 per share (totaling KRW 145.8 billion) for fiscal year 2024 to KRW 1,100 per share (totaling KRW 106.5 billion) for fiscal year 2025 — but the company continues to maintain a stable dividend yield of 1.6%.

The problem is a structural disconnect between earnings and stock performance. After reaching an intraday high of KRW 100,800 in late June last year, the share price has since fallen to the low KRW 60,000s — below the IPO price of KRW 61,900 at the time of its KOSPI listing in February last year.

This disconnect stems in part from the structural absence of treasury shares. When a stock comes under pressure, companies typically deploy buybacks and cancellations to restore market confidence and stabilize the price. LG CNS, however, holds no existing shares and is therefore unable to respond in this manner immediately. For investors, the takeaway is that — beyond dividends — there are few visible shareholder return mechanisms available.

Responding With Value Creation Through M&A and Physical AI

For the time being, LG CNS plans to focus on business expansion rather than treasury shares.

At the annual general shareholders' meeting on March 24, CEO Hyun Shin-kyun stated that the company is "continuously reviewing M&A targets in the areas of smart engineering, smart factory, smart finance, and AI."

The company is also placing considerable emphasis on robotics and physical AI as future growth drivers. LG CNS recently launched the "RX (Robot Transformation) Innovation Lab," a client-tailored robotics consulting unit.

The company is also already collaborating with U.S.-based firms Skilled AI and Contiq to advance its industry-specific robotics foundation model (RFM). This year, LG CNS made a strategic investment in U.S. humanoid robotics company Dexterous, as it moves to secure hardware design capabilities.

CEO Hyun Shin-kyun said, "We are currently conducting proof-of-concept (PoC) tests at industrial sites for robotics applications," adding that "we are also reviewing M&A opportunities across a range of fields, including this area."

Encouragingly, the market has already begun to express optimism about LG CNS's earnings outlook for this year. The company's introduction of the RX strategy as a new growth driver was also met with positive reception. On January 13 — the day CEO Hyun Shin-kyun's strategy was disclosed — LG CNS shares rose 3.97% from the previous session to close at KRW 62,800.

An industry official noted, "While the absence of treasury shares makes short-term price defense difficult, LG CNS's industrial data assets and its position within the LG Group AI ecosystem could become an unmatched competitive advantage in the physical AI market." The official added, "If CEO Hyun Shin-kyun's tenure delivers visible results from the RX full-stack service strategy, a more active discussion of the stock's undervaluation relative to its earnings could well take center stage."

Jeong Chaeyun (chaeyun@fntimes.com)